WO2009025571A1 - Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease - Google Patents
Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease Download PDFInfo
- Publication number
- WO2009025571A1 WO2009025571A1 PCT/RU2007/000446 RU2007000446W WO2009025571A1 WO 2009025571 A1 WO2009025571 A1 WO 2009025571A1 RU 2007000446 W RU2007000446 W RU 2007000446W WO 2009025571 A1 WO2009025571 A1 WO 2009025571A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- succinic acid
- pharmaceutically acceptable
- disease
- sublingual
- treating alzheimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2007/000446 WO2009025571A1 (en) | 2007-08-15 | 2007-08-15 | Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease |
EA201000118A EA201000118A1 (en) | 2007-08-15 | 2007-08-15 | SUBLINGUAL OR TRANSBUCKCAL COMPOSITIONS CONTAINING AMBER ACID AND INTENDED FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2007/000446 WO2009025571A1 (en) | 2007-08-15 | 2007-08-15 | Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009025571A1 true WO2009025571A1 (en) | 2009-02-26 |
Family
ID=39429279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2007/000446 WO2009025571A1 (en) | 2007-08-15 | 2007-08-15 | Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA201000118A1 (en) |
WO (1) | WO2009025571A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5124061A (en) * | 1991-04-01 | 1992-06-23 | Geary Sr Robert J | Systemic plant cryoprotection with choline salts |
WO2003026686A1 (en) * | 2001-09-27 | 2003-04-03 | Pomytkin Igor A | Potentiating the therapeutic effects of interferons |
WO2005000340A1 (en) * | 2003-06-27 | 2005-01-06 | Pomytkin Igor A | Synergistic compositions comprising erythropoietin and succinic acid (salt) |
US20060002989A1 (en) * | 2004-06-10 | 2006-01-05 | Ahmed Salah U | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
US20060199862A1 (en) * | 2005-03-04 | 2006-09-07 | Pomytkin Igor A | Method for enhancing cognitive function |
-
2007
- 2007-08-15 WO PCT/RU2007/000446 patent/WO2009025571A1/en active Application Filing
- 2007-08-15 EA EA201000118A patent/EA201000118A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5124061A (en) * | 1991-04-01 | 1992-06-23 | Geary Sr Robert J | Systemic plant cryoprotection with choline salts |
WO2003026686A1 (en) * | 2001-09-27 | 2003-04-03 | Pomytkin Igor A | Potentiating the therapeutic effects of interferons |
WO2005000340A1 (en) * | 2003-06-27 | 2005-01-06 | Pomytkin Igor A | Synergistic compositions comprising erythropoietin and succinic acid (salt) |
US20060002989A1 (en) * | 2004-06-10 | 2006-01-05 | Ahmed Salah U | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
US20060199862A1 (en) * | 2005-03-04 | 2006-09-07 | Pomytkin Igor A | Method for enhancing cognitive function |
Also Published As
Publication number | Publication date |
---|---|
EA201000118A1 (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5555634B2 (en) | Method for treating vitamin B12 deficiency | |
AU2007298814B2 (en) | Galenic form for the trans-mucosal delivery of active ingredients | |
JP2002511409A (en) | Treatment of neuropsychiatric disorders | |
RU2501808C1 (en) | Composition for improvement of brain function and method for improvement of brain function | |
AU2010360967B2 (en) | Nicotine containing formulation | |
JP2021088575A (en) | Methods for treating gi tract disorders | |
MX2008014941A (en) | Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty. | |
WO2012000377A1 (en) | Pharmaceutical composition comprising levocarnitine and dobesilate | |
AU2013346766B2 (en) | Effervescent tablet | |
WO2009025571A1 (en) | Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease | |
RU2461374C1 (en) | Biologially active agent having effect on general metabolic, excitatory and inhibitory nerve function and intellectual mnestic cerebral functions (versions) | |
RU2396076C1 (en) | Agent reducing degree of acute alcohol intoxication (inebriation) and exhibiting anti-hungover action, biologically active additive, pharmaceutical composition, drug and method for preparing thereof | |
EP4243797A1 (en) | Rapidly infusing platform and compositions for therapeutic treatment in humans | |
JP2019515045A (en) | Compositions and Methods for Providing Thyroid Hormone or Analogs Thereof | |
EP2185147A1 (en) | Intranasal pharmaceutical compositions comprising succinic acid and methods thereof | |
WO2009022932A1 (en) | Pharmaceutical compositions comprising monocholine succinate salts | |
ES2732865T3 (en) | Antimicrobial compositions with effervescent agents | |
RU2358723C1 (en) | Antiwithdrawal agent, biologically active additive, pharmaceutical composition, medical product and method of producing | |
CN106822158B (en) | Salidroside for preventing and treating obstructive sleep apnea induced hypertension | |
ES2548090T3 (en) | Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma | |
ES2515840T3 (en) | Steroidal compositions containing hydroxycarboxylic acids and methods for using them | |
WO2023224960A1 (en) | Rapidly infusing cannabinoid compositions, processes of manufacture, and methods of use | |
JPH11130671A (en) | Aldose reductase inhibitor | |
WO2014205654A1 (en) | Compound pharmaceutical compositions for treating pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07870605 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201000118 Country of ref document: EA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 18/06/2010) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07870605 Country of ref document: EP Kind code of ref document: A1 |